Fri, July 28, 2023
Thu, July 27, 2023
Wed, July 26, 2023

Jonathan Yong Reiterated (AMED) at Hold and Held Target at $101 on, Jul 27th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-101-on-jul-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jonathan Yong of Credit Suisse, Reiterated "Amedisys, Inc." (AMED) at Hold and Held Target at $101 on, Jul 27th, 2023.

Jonathan has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, all agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $101 on, Thursday, July 6th, 2023
  • Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Wednesday, June 28th, 2023
  • David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $101 on, Tuesday, June 27th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
  • Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023